CHINA’S pharmaceutical companies should pursue more opportunities overseas and seek greater collaboration with foreign partners, an industry official said yesterday.
“Chinese pharma companies and manufacturers should allocate more resources to the international market in the next five years so that they can play a more important role,” Xu Ming, vice president of the China Chamber of Commerce for Import & Export of Medicines & Health Products, told a press conference.
He was speaking ahead of the 16th International Convention on Pharmaceutical Ingredients, which is co-organized by the chamber.
As one of the world’s biggest exporters and manufacturers of pharmaceutical ingredients, China should focus more on foreign markets, he said.
The chamber will seek to promote industry collaboration between China and central and eastern Europe countries at the upcoming convention, Xu said.